Statement Of Financial Position [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166254

Concept	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	176,000 EUR	—	—	—	—	—	—	—	—	122,000 EUR	—	—	—	—	—	—	—	—	—	—	—
Intangible assets other than goodwill	3,607 EUR	—	—	—	—	—	—	—	—	2,944 EUR	—	—	—	—	—	—	—	—	—	—	—
Investments accounted for using equity method	3,948 EUR	—	—	—	—	—	—	—	—	4,079 EUR	—	—	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	43,457 EUR	—	—	—	—	—	—	—	—	50,012 EUR	—	—	—	—	—	—	—	—	—	—	64,399 EUR
Assets	61,864 EUR	—	—	—	—	—	—	—	—	63,444 EUR	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	140,000 EUR	—	—	—	—	—	—	—	—	129,000 EUR	—	—	—	—	—	—	—	—	—	—	—
Retained earnings	53,476 EUR	—	—	—	—	—	—	—	—	43,226 EUR	—	—	—	—	—	—	—	—	—	—	—
Share premium	121,513 EUR	—	—	—	—	—	—	—	—	103,693 EUR	—	—	—	—	—	—	—	—	—	—	—
Other reserves	476,000 EUR	—	—	—	—	—	—	—	—	476,000 EUR	—	—	—	—	—	—	—	—	—	—	—
Equity	55,045 EUR	476,000 EUR	4,460 EUR	121,513 EUR	1,622 EUR	64,246 EUR	140,000 EUR	54,805 EUR	476,000 EUR	48,056 EUR	3,827 EUR	103,693 EUR	2,391 EUR	129,000 EUR	43,226 EUR	129,000 EUR	3,827 EUR	476,000 EUR	1,814 EUR	103,693 EUR	59,059 EUR
Liabilities [abstract]
Liabilities	6,819 EUR	—	—	—	—	—	—	—	—	15,388 EUR	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities	61,864 EUR	—	—	—	—	—	—	—	—	63,444 EUR	—	—	—	—	—	—	—	—	—	—	—